Discovery to Market
Discovery to Market articles place a focus on the commercial side of research and how scientific discoveries can impact the public.
Why We Still Talk About Smallpox, Years After Eradicating the Virus
The smallpox virus terrorized humankind for thousands of years. Even if victims survived the infection, smallpox often led to permanent blindness and disfigurement. This plague upon humanity finally ended in 1980 after a worldwide vaccination [...]
Me-Too Drugs: An Innovation Killing Strategy?
Scientific advancement is built upon past knowledge. The successes (and failures) of generations of scientists shape how we understand the world today. This is also true in medicinal chemistry, where new drugs are constantly being [...]
What Dallas Buyers Club Doesn’t Tell You About AZT and Peptide T
The AIDS/HIV pandemic of 1981 took everyone by surprise. In the U.S., the FDA and pharmaceutical companies raced to test the effectiveness of drug candidates like AZT in clinical trials. Many patients turned to unproven, [...]
Insulin: From Inspiring Discovery to Deadly Expense
Half a billion people today suffer from diabetes, a disease that causes high blood glucose levels. Although no cure exists as yet, the remarkable discovery and subsequent development of insulin injections have allowed millions of [...]
Graphene May Be a Wonder Material, But Don’t Hold Your Breath
The discovery of graphene back in 2004 brought about the prospect of exciting new possibilities. Light as a feather yet stronger than Kevlar, many believed graphene to be a wonder material, capable of changing the [...]
Evaluating Modafinil as a Smart Drug (20 Years of Data)
Modafinil (Provigil) first entered the U.S. markets in 1998 after FDA approval. Although it was initially intended to treat narcolepsy and related sleep disorders, it quickly garnered a reputation as an off-label ‘smart drug’. We [...]
